ELEvdoxia Eirini Lithoxoidou

Evdoxia Eirini Lithoxoidou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evdoxia Eirini Lithoxoidou has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI Assistants Based on Large Language Models for Adolescent Health and Well-Being: A Systematic Review

    by Andreas Triantafyllidis, Sofia Segkouli, Evdoxia Eirini Lithoxoidou, Anastasios Alexiadis, Konstantinos Votis, Kleio Koutra, Vassilis Kilintzis, Haridimos Kondylakis, Eunate Arana-Arri, Severin Haug, et al.

    Objective: Large Language Models (LLMs) are emerging as a key component for digital health systems based on Artificial Intelligence (AI). The objective of this paper is to systematically review the characteristics, effectiveness, and implementation challenges of LLM-based assistants targeting adolescent health and well-being. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed, Scopus, and Web of Science were searched in November 2025 for studies published from 2022 onwards. Eligible studies examined LLM-based assistants used directly by adolescents in health and well-being contexts and reported quantitative outcomes. Data was extracted independently by multiple reviewers and synthesised narratively. Risk of bias was assessed using the Mixed Methods Appraisal Tool (MMAT). Results: Nine studies met the inclusion criteria, involving between 3 and 40 participants and covering mental health support, physical activity promotion, treatment engagement, vaccination awareness, and academic self-efficacy. Most studies were proof-of-concept investigations or pilot studies. LLM-based assistants were associated with reductions in depression, anxiety, stress, and negative affect, improvements in emotional regulation, physical activity, treatment motivation, HPV knowledge, and academic self-efficacy. Risk of bias was generally moderate and the evidence base was limited by small samples, short follow-up periods, and heterogeneous methodologies. Conclusions: LLM-based assistants show promise as scalable and accessible tools for supporting adolescent health and well-being, particularly in mental health domains. However, the current evidence remains preliminary. Larger, long-term, and rigorously designed studies are required to establish effectiveness, safety, and implementation feasibility. Registration: This review was not pre-registered and no review protocol has been published prior to conducting the review.

  • Multidimensional Approach Fostering Sustainable Tourism Growth in Rural and Remote Regions

    by Evdoxia Eirini Lithoxoidou, Stelios Krinidis, Polyvios Raxis, Vasiliki Drouga, Dimosthenis Ioannidis, Dimitrios Tzovaras

  • Open Access

    ExpertAssist: An “On-the-Job” augmented reality toolkit for assistance in the construction industry

    by Ilias Chrysovergis, Evdoxia Eirini Lithoxoidou, Dimitris Pallantzas, Athanasios Tsakiris, Dimosthenis Ioannidis, Dimitrios Tzovaras

  • Open Access

    Large Language Models for Cardiovascular Disease, Cancer, and Mental Disorders: A Review of Systematic Reviews

    by Andreas Triantafyllidis, Sofia Segkouli, Stelios Kokkas, Anastasios Alexiadis, Evdoxia Eirini Lithoxoidou, George Manias, Athos Antoniades, Konstantinos Votis, Dimitrios Tzovaras

    Background/Objective: The use of Large Language Models (LLMs) has recently gained significant interest from the research community toward the development and adoption of Generative Artificial Intelligence (GenAI) solutions for healthcare. The present work introduces the first meta-review (i.e., review of systematic reviews) in the field of LLMs for chronic diseases, focusing particularly on cardiovascular, cancer, and mental diseases, to identify their value in patient care, and challenges for their implementation and clinical application. Methods: A literature search in the bibliographic databases of PubMed and Scopus was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to identify systematic reviews incorporating LLMs. The original studies included in the reviews were synthesized according to their target disease, specific application, LLMs used, data sources, accuracy, and key outcomes. Results: The literature search identified 5 systematic reviews respecting our inclusion and exclusion criteria, which examined 81 unique LLM-based solutions. The highest percentage of the solutions targeted mental disease (86%), followed by cancer (7%) and cardiovascular disease (6%), implying a large research focus in mental health. Generative Pre-trained Transformer (GPT)-family models were used most frequently (~55%), followed by Bidirectional Encoder Representations from Transformers (BERT) variants (~40%). Key application areas included depression detection and classification (38%), suicidal ideation detection (7%), question answering based on treatment guidelines and recommendations (7%), and emotion classification (5%). Study aims and designs were highly heterogeneous, and methodological quality was generally moderate with frequent risk-of-bias concerns. Reported performance varied widely across domains and datasets, and many evaluations relied on fictional vignettes or non-representative data, limiting generalisability. The most significant found challenges in the development and evaluation of LLMs include inconsistent accuracy, bias detection and mitigation, model transparency, data privacy, need for continual human oversight, ethical concerns and guidelines, as well as the design and conduction of high-quality studies. Conclusions: While LLMs show promise for screening, triage, decision support, and patient education—particularly in mental health—the current literature is descriptive and constrained by data, transparency, and safety gaps. We recommend prioritizing rigorous real-world evaluations, diverse benchmark datasets, bias-auditing, and governance frameworks before LLM clinical deployment and large adoption.


  • Open Access

    Large Language Models for Cardiovascular Disease, Cancer, and Mental Disorders: A Review of Systematic Reviews

    by Andreas Triantafyllidis, Sofia Segkouli, Stelios Kokkas, Anastasios Alexiadis, Eirini Lithoxoidou, George Manias, Athos Antoniades, Konstantinos Votis, Dimitrios Tzovaras

    Background/Objective: The use of Large Language Models (LLMs) has recently gained significant interest from the research community toward the development and adoption of Generative Artificial Intelligence (GenAI) solutions for healthcare. The present work introduces the first meta-review (i.e., review of systematic reviews) in the field of LLMs for chronic diseases, focusing particularly on cardiovascular, cancer, and mental diseases, with the goal to identify their value in patient care, as well as challenges for their implementation and clinical application. Methods: A literature search in the bibliographic databases of PubMed and Scopus was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, in order to identify systematic reviews incorporating LLMs. The original studies included in the reviews were synthesized according to their target disease, specific application, used LLMs, data sources, accuracy, and key outcomes. Results: The literature search identified 5 systematic reviews respecting our inclusion and exclusion criteria, which examined 81 unique LLM-based solutions. The highest percentage of the solutions targeted mental disease (70 studies, 86%), followed by cancer (6 studies, 7%) and cardiovascular disease (5 studies, 6%). Generative Pre-trained Transformer (GPT) models were used in most studies (45 studies, 55%), followed by Bidirectional Encoder Representations from Transformers (BERT) models (33 studies, 40%). Key application areas included depression detection and classification (31 studies, 38%), suicidal ideation detection (6 studies, 7%), question answering based on treatment guidelines and recommendations (6 studies, 7%), and emotion classification (4 studies, 5%). Studies were highly heterogeneous, with most studies (41 studies, 50%) focusing on clinical/diagnostic accuracy using metrics for correct diagnosis, agreement with guidelines or model performance, whereas other studies (34 studies, 42%) were descriptive and focused on narrative outcomes, usability, trust or plausibility. The most significant found challenges in the development and evaluation of LLMs include inconsistent accuracy, bias detection and mitigation, model transparency, data privacy, need for continual human oversight, ethical concerns and guidelines, as well as the design and conduction of high-quality studies. Conclusion: The results of this review suggest LLMs could become valuable tools for enhancing diagnostic precision and decision support in cardiovascular disease, cancer and mental health . Given the limited number of studies included in this review and their moderate quality, we urge the research community to conduct more investigations in real-world intervention settings to better demonstrate the clinical utility of LLMs.


  • Open Access

    Advancing Affective Intelligence in Virtual Agents Using Affect Control Theory

    by Evdoxia Eirini Lithoxoidou, George Eleftherakis, Konstantinos Votis, Tony Prescott


  • A Virtual Coach and a Worker Dashboard to Promote Well-Being and Workability: An Acceptance Study

    by Evdoxia-Eirini Lithoxoidou, Rafail-Evangelos Mastoras, Aris Papaprodromou, Charalampos Georgiadis, Patricia Abril Jimenez, Sergio Gonzalez, Maria Fernanda Cabrera-Umpierrez, Maria Loeck, Rosa Carreton, Sofia Segkouli, et al.